Rise, and pronounced regional variation, in methylphenidate, amphetamine, and lisdexamfetamine distribution in the United States

Rise and regional disparities in buprenorphine utilization in the United States

(2020) Amir R. Pashmineh Azar et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Assessment of Controlled Substance Distribution to U.S. Veterinary Teaching Institutions From 2006 to 2019

(2020) Brian J. Piper et al.   Frontiers in Veterinary Science

Opioid Prescribing Laws Are Not Associated with Short-term Declines in Prescription Opioid Distribution

(2019) Corey S Davis et al.   PAIN MEDICINE

Trends in the medical supply of fentanyl and fentanyl analogues: United States, 2006 to 2017

(2019) Lacee K. Collins et al.   PREVENTIVE MEDICINE

Trends in Medical Use of Opioids in the U.S., 2006–2016

(2018) Brian J. Piper et al.   AMERICAN JOURNAL OF PREVENTIVE MEDICINE

Pediatric ADHD Medication Exposures Reported to US Poison Control Centers

(2018) Samantha A. King et al.   PEDIATRICS

Racial-Ethnic Differences in Patterns of Discontinuous Medication Treatment Among Medicaid-Insured Youths With ADHD

(2018) Xu Ji et al.   PSYCHIATRIC SERVICES

Attention-Deficit/Hyperactivity Disorder Medication Prescription Claims Among Privately Insured Women Aged 15–44 Years — United States, 2003–2015

(2018) Kayla N. Anderson et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Increased risk of diseases of the basal ganglia and cerebellum in patients with a history of attention-deficit/hyperactivity disorder

(2018) Karen Curtin et al.   NEUROPSYCHOPHARMACOLOGY

Longitudinal Trends in the Diagnosis of Attention-Deficit/Hyperactivity Disorder and Stimulant Use in Preschool Children on Medicaid

(2018) Deborah Winders Davis et al.   JOURNAL OF PEDIATRICS

Trends in use of prescription stimulants in the United States and Territories, 2006 to 2016

(2018) Brian J. Piper et al.   PLoS One

Hispanic Residential Isolation, ADHD Diagnosis and Stimulant Treatment among Medicaid-insured Youth

(2017) Dinci Pennap et al.   ETHNICITY & DISEASE

An update on the safety of psychostimulants for the treatment of attention-deficit/hyperactivity disorder

(2017) Annabeth P. Groenman et al.   Expert Opinion On Drug Safety

High-Expenditure Pharmaceutical Use Among Children in Medicaid

(2017) Eyal Cohen et al.   PEDIATRICS

Racial and Ethnic Differences in ADHD Treatment Quality Among Medicaid-Enrolled Youth

(2017) Janet R. Cummings et al.   PEDIATRICS

Medicaid Prior Authorization Policies for Medication Treatment of Attention-Deficit/Hyperactivity Disorder in Young Children, United States, 2015

(2017) Rachel L. Hulkower et al.   PUBLIC HEALTH REPORTS

Alternative pharmacological strategies for adult ADHD treatment: a systematic review

(2016) Massimiliano Buoli et al.   Expert Review of Neurotherapeutics

Racial and Ethnic Disparities in Mental Health Care for Children and Young Adults

(2016) Lyndonna Marrast et al.   INTERNATIONAL JOURNAL OF HEALTH SERVICES

Alternative pharmacological strategies for adult ADHD treatment: a systematic review

(2016) Massimiliano Buoli et al.   Expert Review of Neurotherapeutics

Comparison of lisdexamfetamine and dextroamphetamine exposures reported to U.S. poison centers

(2015) Mingzohn Ellen Kaland et al.   CLINICAL TOXICOLOGY

Methamphetamine/amphetamine abuse and risk of Parkinson's disease in Utah: A population-based assessment

(2015) Karen Curtin et al.   DRUG AND ALCOHOL DEPENDENCE

ADHD Prevalence: Altitude or Sunlight? Better Understanding the Interrelations of Dopamine and the Circadian System

(2015) Martijn Arns et al.   Journal of Attention Disorders

Association Between Altitude and Regional Variation of ADHD in Youth

(2015) Rebekah S. Huber et al.   Journal of Attention Disorders

State Variation in Increased ADHD Prevalence: Links to NCLB School Accountability and State Medication Laws

(2015) Brent D. Fulton et al.   PSYCHIATRIC SERVICES

A Systematic Review of the Safety of Lisdexamfetamine Dimesylate

(2014) David R. Coghill et al.   CNS DRUGS

Long-Term Stimulant Treatment Affects Brain Dopamine Transporter Level in Patients with Attention Deficit Hyperactive Disorder

(2013) Gene-Jack Wang et al.   PLoS One

Changes in the definition of ADHD in DSM-5: subtle but important

(2013) Jeffery N Epstein et al.   Neuropsychiatry

Striatal Dopamine Transporter Alterations in ADHD: Pathophysiology or Adaptation to Psychostimulants? A Meta-Analysis

(2012) Paolo Fusar-Poli et al.   AMERICAN JOURNAL OF PSYCHIATRY

Medicaid Expenditures on Psychotropic Medications for Children in the Child Welfare System

(2012) Ramesh Raghavan et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents

(2011)   PEDIATRICS

Use of Psychostimulants in Patients with Dementia

(2010) Christian R Dolder et al.   ANNALS OF PHARMACOTHERAPY